Full name
STEM CELL THERAPIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
86.10.Z - Hospital activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 19,7 | 14,8 | 13,1 | -11,5 |
Gross profit (loss) | -5,2 | -5,2 | -2,1 | 60,5 |
Net profit (loss) | -5,2 | -5,2 | -2,1 | 60,5 |
Cash | 8,5 | 8 | 7,7 | -3,4 |
Liabilities and provisions for liabilities | 1,4 | 1,8 | 2,1 | 21 |
Net income from sale | 0 | 0 | 0 | 0 |
Short time liabilities | 1,4 | 1,8 | 2,1 | 21 |
Equity capital | 18,3 | 13,1 | 11 | -15,8 |
Working assets | 13,8 | 13,3 | 13,1 | -1,5 |
Operating profit (EBIT) | -5,2 | -5,3 | -2,1 | 60,2 |
% | % | % | p.p. | |
Equity capital to total assets | 93 | 88,1 | 83,8 | -4,3 |
Gross profit margin | -123,2 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 9.924057006835938 | 7.5807061195373535 | 6.1714186668396 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane